Sign in

CIK 0001723128

  • Large accelerated filer

Amneal Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 908-947-3120
Former names
Atlas Holdings, Inc.
  1. 4 Open-market sale Executive Vice President sold 71,694 shares at $9.29 ($666,037)
  2. 4 Open-market sale Executive Vice President & CFO sold 499,730 shares at an average $9.33 ($4,663,070)
  3. 4 Open-market sale Executive Vice President sold 50,000 shares at $9.04 ($452,000)
  4. 4 Open-market sale EVP, Chief Legal Officer sold 22,000 shares at $9.05 ($199,100)
  5. 4 Open-market sale Executive Vice President sold 33,436 shares at $9.05 ($302,596)
  6. 4 Planned sale Director sold 94,906 shares at $8.02 ($761,146)
  7. 4 Open-market sale Director sold 56,426 shares at $8.02 ($452,537)
  8. 4 Open-market sale Executive Vice President sold 49,140 shares at $7.58 ($372,481)
  9. 4 Open-market sale Director sold 50,000 shares at $7.59 ($379,500)
  10. 4 Option exercise Director acquired 40,258 shares (option exercise)
  11. 4 Option exercise Director acquired 40,258 shares (option exercise)
  12. 4 Option exercise Director acquired 40,258 shares (option exercise)
  13. 4 Option exercise Director acquired 40,258 shares (option exercise)
  14. 4 Option exercise Director acquired 40,258 shares (option exercise)
  15. 4 Option exercise Director acquired 40,258 shares (option exercise)
  16. 4 Option exercise Director acquired 40,258 shares (option exercise)
  17. 4 Option exercise Director acquired 56,361 shares (option exercise)
  18. 4 Option exercise Director acquired 40,258 shares (option exercise)
  19. 4 Open-market sale Director sold 8,668 shares at $8.00 ($69,344)
  20. 4 Open-market sale Director sold 80,000 shares at $8.30 ($664,000)

Page 3 of 18 · 351 filings